Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australian Study Says Most Weight-Loss Drugs Never Tested (Australia)

This article was originally published in PharmAsia News

Executive Summary

An Australian study says the country's regulations governing complementary medicines need to be overhauled so the sale of many weight-loss drugs can be halted. The study made the recommendation as a result of an investigation of many of the products, finding they either do no work at all or were never properly tested. The researcher behind the study said the Therapeutic Goods Administration assumes the weight-loss medicines are harmless, but Dr. Ken Harvey of La Trobe University said that theory is out of date by 10 or 15 years. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC066799

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel